1. Hemodialysis and water quality. Coulliette and Arduino. Semin Dial. 2013: 26:427-438.
综述，回顾透析用水的质量标准，化学和微生物污染物的爆发及感染控制的方案。
2. The economics of hemodialysis catheter-related infection prophylaxis. Kosa and Lok. Semin Dial. 2013: 26:482-493.
综述，回顾导管相关感染的花费，感染的预防策略和预防方案的执行。
3. Phosphate control in end-stage renal disease: barriers and opportunities. Waheed, et al. Nephrol Dial Transplant. 2013 Dec;28(12):2961-8.
综述，回顾血磷控制的障碍和机遇，包括强化HD治疗效果的讨论内容。
4. Diastolic Dysfunction and High Levels of New Cardiac Biomarkers as Risk Factors for Cardiovascular Events and Mortality in Hemodialysis Patients. Quiroga B.a, et al. Blood Purif 2013; 36(2):98-106.
心脏舒张功能不全是透析患者死亡和心血管事件（CVE）的紧急危险因素。低白蛋白也提示存在CVE风险。非自体血管通路和低白蛋白是死亡的高危因素。
5. Trends in Hip Fracture Rates in US Hemodialysis Patients,1993-2010. Thomas J. Arneson, et al. Am J Kidney Dis. 2013; 62(4):747-754.
不同于非终末期肾病的医疗保险患者髋部骨折发生率下降的趋势，HD患者呈现出短时的较快增长，直到2004年才开始下降。需要进一步的研究去解释相关原因。
6. Associations of Frequency and Duration of Patient-Doctor Contact in Hemodialysis Facilities with Mortality. Takehiko Kawaguchi, et al. J Am Soc Nephrol 2013 Sept; 24(9): 1493-1502.
医患之间频繁、长时的交流可以改善HD患者的预后，但是需要政策导向的支持。
7. Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs. Werner Kleophas, et al. Kidney International (2013) 84: 578–584.
在实施统一报销制度后，提高血液透析质量已经成为德国各透析中心的趋势，因此，在控制成本的前提下，医疗模式的分析对于维持高质量的护理水平是非常必要的。
8. Quality of life and mental health related to timing, frequency, and dose of hemodialysis. Cohen and Kimmel. Semin Dial. 2013 Nov;26(6):697-701.
总结了透析开始时机、更频繁的透析以及增加的透析剂量对生活质量和心理健康的影响。
9. Frequent hemodialysis: a critical review. Diaz‐Buxo, et al. Semin Dial. 2013;25: 578‐589.
综述，比较了当前的高频HD与常规HD在生存率、生活质量和其他临床终点方面的数据。
10. Effect of switching to nocturnal thrice‐weekly hemodialysis on clinical and laboratory parameters: our clinical experience. Gubensek, et al. Ther Apheresis Dial. 2013;17:412‐415.
夜间HD（3 x 8 小时）改善了血磷及血钾控制水平，并且降低了磷结合剂的使用。
11. Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis. Wang, et al. Nephrol Dial Transplant. Published online September 5, 2012.
患者对于服药的顺应性与药物片剂数量及血磷水平成负相关，与患者血磷达标呈正相关。
12. Procedure‐related serious adverse events among home hemodialysis patients: a quality assurance perspective. Wong, et al. Am J Kidney Dis. 2013; online publication.
加拿大两个持续11年的项目经验表明，居家HD过程中危及生命的不良事件是不常见的。
13. Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Zaritsky, et al. Nephrol Dial Transplant. Published online September 5, 2013.
FGF23水平在每日短时透析的患者中是比较低的，这或许是比血磷更敏感的反映磷负荷的生物标记物。
14. Temporal Risk Profile for Infectious and Noninfectious Complications of Hemodialysis Access. Pietro Ravani, et al. J Am Soc Nephrol 2013 Sept; 24(10): 1668-1677.
随着血液透析时间的延长，由此产生的非感染性或感染性血管通路并发症的风险会降低，建议在血管通路形成后的6个月之内做预防工作。
15. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. J Park et al.Kidney International (2013) 84, 795–802.
HD后血压适度下降与较好的生存率相关，而上升或者较大幅度的下降都与生存率较差相关。
16. Time to recovery after a hemodialysis session: impact of selected variables. Awuah, et al. Clin Kidney J. Published online September 29, 2013.
在常规的一次HD治疗后，患者的恢复时间并不受人口统计学和临床因素影响。
17. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. Lertdumrongluk, et al. J Renal Nutrition. 2013;23:411-421.
各年龄组的HD患者中均观察到高磷血症与死亡率增高相关。
18. Cardiovascular benefits of daily hemodialysis: peeling the onion. McIntyre CW. Nephrol Dial Transplant. Published online October 21, 2013 (Chan, et al. Nephrol Dial Transplant. Published online September 26, 2013).
编辑对FHN研究中影响心率变异性方面的评论。
19. Intensified home hemodialysis: clinical benefits, risks and target populations. Tennankore, et al. Nephrol Dial Transplant. Published online October 28, 2013.
提出强化的居家血液透析(IHHD)的定义和内容，讨论这种治疗方式的临床益处/风险，并识别适合这种治疗方式的目标人群。
20. Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium. Thomson, et al. Hemodial Int. 2013; 17: 576 -585.
透析期间体重增加的可调节危险因素包括透析时间、透析频率以及透析液钠浓度。
21. Infrequent dialysis: a new paradigm for hemodialysis initiation. Rhee CM, et al. Semin Dial. 2013 Nov;26(6):720-7.
综述：概述了血液透析后残肾功能的临床变化，研究每周两次的透析方案，并阐述了这种低频血液透析的潜在风险和益处。
22. Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients. Zhang K, et al. BMC Nephrol. Published online Nov 14, 2013.
长期口服小剂量维生素C，可以部分改善伴有维生素C缺乏症的维持性血液透析患者的炎症状态并部分改善炎症标志物水平。